Lazard Asset Management
HOOK

Lazard Asset Management’s HOOKIPA Pharma HOOK Stock Holding History

Lazard Asset Management’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-218
Closed – – 2383
2024
Q3 		$0 Buy
218
+93
+74% +$491 ﹤0.01% 2344
2024
Q2 		$0 Buy
+125
New +$991 ﹤0.01% 2322

Other funds holding HOOK

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Lazard Asset Management's HOOK Position: Q4 2024 in Review

Lazard Asset Management sold out of HOOKIPA Pharma (HOOK) in Q4 2024, closing a stake of 218 shares.

Lazard Asset Management first reported a position in HOOK in Q2 2024 and held it in 2 quarters. The position peaked at $0 in Q3 2024. 38 funds tracked by Wall St. Rank hold HOOK as of Q4 2024.

  • Lazard Asset Management reported no remaining HOOKIPA Pharma position as of Q4 2024 after selling out during the quarter.
  • Lazard Asset Management sold 218 HOOKIPA Pharma shares in Q4 2024.
  • Lazard Asset Management first reported a position in HOOKIPA Pharma in Q2 2024 and held it in 2 quarters.
  • Lazard Asset Management's HOOKIPA Pharma position peaked at $0 in Q3 2024.
  • 38 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q4 2024.

Based on Lazard Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.